These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. Fixed drug eruption due to metronidazole and tinidazole without cross-sensitivity to secnidazole. Thami GP, Kanwar AJ. Dermatology; 1998 May; 196(3):368. PubMed ID: 9621157 [No Abstract] [Full Text] [Related]
67. Refractory giardiasis in renal transplantation: a case report. Mukku KK, Raju S, Yelanati R. Nephrology (Carlton); 2015 Jan; 20(1):44. PubMed ID: 25535868 [No Abstract] [Full Text] [Related]
71. Comparative efficacy of drugs for treating giardiasis: a systematic update of the literature and network meta-analysis of randomized clinical trials. Ordóñez-Mena JM, McCarthy ND, Fanshawe TR. J Antimicrob Chemother; 2018 Mar 01; 73(3):596-606. PubMed ID: 29186570 [Abstract] [Full Text] [Related]
73. [Experimental study of a new anti-lambliasis preparation Chlodophen--bis(2,4-dichlorophenyliodonium) chloride]. Pershin GN, Novitskaia NA, Milovanova SN, Zykova TN. Med Parazitol (Mosk); 1971 Mar 01; 40(1):78-81. PubMed ID: 5087694 [No Abstract] [Full Text] [Related]
74. [Activity of the cyclic adenosine monophosphate phosphodiesterase of the blood lymphocytes in patients with a Lamblia infection susceptible and resistant to lambliacides]. Kochetkova MN, Ezhkova NG, Ozeretskovskaia NN. Med Parazitol (Mosk); 1986 Mar 01; (5):46-9. PubMed ID: 3025575 [No Abstract] [Full Text] [Related]